#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour Osteosarcoma Congenital disorder of glycosylation Myxoid liposarcoma Skin cancer Philadelphia positive acute lymphocytic leukaemia Neuromyelitis optica spectrum disorder Prader-Willi syndrome Haemophilia B with anti factor IX Bronchiectasis Cholestatic pruritus Angiosarcoma metastatic Myeloid leukaemia Becker's muscular dystrophy Myxofibrosarcoma More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Basic Information Sarcoidosis – Basic Information Pelizaeus-Merzbacher disease – Diagnostics Marginal zone lymphoma refractory – Treatment Haemophilia A without inhibitors – Life with Disease Langerhans cell sarcoma – Life with Disease Glycogen storage disease type II – Diagnostics Antithrombin III deficiency – Basic Information Angiosarcoma metastatic – Treatment CADASIL – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alternaria Alternata Extract Methoxsalen Cipepofol Magnesium Stearate Rgx-202 Ulonivirine Olmesartan Medoxomil Ecoo16 Pemigatinib Pimozide Zoledronic Acid Monohydrate Capivasertib Kbp-336 Tacrolimus Monohydrate TRIACYLGLYCEROL LIPASE Rtp-026 Sodium [11C]Az14193391 Navtemadlin Sotalol Ergocalciferol More therapies…

    Learn about Your Condition

    Rectal cancer stage III Venous thrombosis Optic ischaemic neuropathy Andersen-Tawil syndrome Mitral valve prolapse Autoimmune hepatitis Mitochondrial DNA depletion Brain abscess Asplenia Polymyalgia rheumatica Thyroid disorder Binge eating Giardiasis Oxygen saturation Complicated appendicitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effects of Rapcabtagene Autoleucel, Tocilizumab, Fludarabine Phosphate, and Cyclophosphamide for Patients with Rheumatoid Arthritis and Sjogren’s Disease

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    France Germany Hungary Italy Spain
  • Study on the Effectiveness of Tezepelumab for Adults with Eosinophilic Granulomatosis with Polyangiitis (EGPA)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    Investigated Drugs:
    • Tezepelumab
    • Placebo
    Italy
  • Study on Aztreonam, Avibactam, and Metronidazole for Treating Infections in Neonates and Infants Under 9 Months with Gram-Negative Bacterial Infections

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    • Abdominal infection
    • Haematological infection
    Investigated Drugs:
    • Avibactam Sodium
    • Aztreonam
    • Metronidazole
    Bulgaria Greece Hungary Italy Slovakia Spain
  • Study of Pembrolizumab for Patients with High-Risk Stage IIB/IIC Melanoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Pembrolizumab
    France
  • Study on Detecting Sentinel Lymph Nodes in Early Oral Cancer Using Gallium-68-Tilmanocept and Technetium-99m in Patients with Oral Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of the oral cavity
    Investigated Drugs:
    • Technetium (99Mtc)
    • Tilmanocept
    • Gallium (68Ga) Chloride
    The Netherlands
  • Study on the Safety and Effectiveness of Tacrolimus and Drug Combination for Patients with BK Polyomavirus Infection After Kidney Transplantation

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Azathioprine
    • Belatacept
    • Ciclosporin
    Germany
Previous Page
1 … 812 813 814 815 816 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!